- Home
- BOW vs QURE Comparison
BOW vs QURE Comparison
Compare BOW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOW
- QURE
- Stock Information
- Founded
- BOW 2020
- QURE 1998
- Country
- BOW United States
- QURE Netherlands
- Employees
- BOW N/A
- QURE N/A
- Industry
- BOW Property-Casualty Insurers
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BOW Finance
- QURE Health Care
- Exchange
- BOW Nasdaq
- QURE Nasdaq
- Market Cap
- BOW 861.2M
- QURE 866.3M
- IPO Year
- BOW 2024
- QURE 2007
- Fundamental
- Price
- BOW $24.91
- QURE $58.99
- Analyst Decision
- BOW Buy
- QURE Strong Buy
- Analyst Count
- BOW 7
- QURE 12
- Target Price
- BOW $36.29
- QURE $69.67
- AVG Volume (30 Days)
- BOW 339.7K
- QURE 3.5M
- Earning Date
- BOW 11-04-2025
- QURE 10-29-2025
- Dividend Yield
- BOW N/A
- QURE N/A
- EPS Growth
- BOW 41.97
- QURE N/A
- EPS
- BOW 1.47
- QURE N/A
- Revenue
- BOW $492,071,000.00
- QURE $14,337,000.00
- Revenue This Year
- BOW $17.36
- QURE N/A
- Revenue Next Year
- BOW $23.19
- QURE $229.18
- P/E Ratio
- BOW $16.95
- QURE N/A
- Revenue Growth
- BOW 41.21
- QURE N/A
- 52 Week Low
- BOW $23.70
- QURE $5.35
- 52 Week High
- BOW $42.29
- QURE $65.14
- Technical
- Relative Strength Index (RSI)
- BOW 39.41
- QURE 61.31
- Support Level
- BOW $24.46
- QURE $57.64
- Resistance Level
- BOW $25.63
- QURE $64.75
- Average True Range (ATR)
- BOW 0.95
- QURE 4.34
- MACD
- BOW 0.02
- QURE -1.44
- Stochastic Oscillator
- BOW 19.90
- QURE 55.51
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.